Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Interferon Type II. Found 7 abstracts

MacFarlane AW, Yamazaki T, Fang M, Sigal LJ, Kurosaki T, Campbell KS. Enhanced NK-cell development and function in BCAP-deficient mice. Blood. 2008 Jul;112(1):131-40.
Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biol Ther. 2003 Jul;2(4):446-51.
Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res. 2003 Apr;9(4):1517-27.
Patterson CE, Lawrence DM, Echols LA, Rall GF. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol. 2002 May;76(9):4497-506.
Slingluff CL, Yamshchikov G, Neese P, Galavotti H, Eastham S, Engelhard VH, Kittlesen D, Deacon D, Hibbitts S, Grosh WW, Petroni G, Cohen R, Wiernasz C, Patterson JW, Conway BP, Ross WG. Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. Clin Cancer Res. 2001 Oct;7(10):3012-24.
Guo JT, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Barrasa MI, Mason WS, Seeger C. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol. 2000 Feb;74(3):1495-505.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Interferon Type II

Interferon Type II immunology metabolism Non-US Gov't Support Female US Gov't Support-PHS Apoptosis genetics Male Human Mice biosynthesis cytology CD8-Positive T-Lymphocytes CD4-Positive T-Lymphocytes Molecular Sequence Data Inbred C57BL Mice Immunoglobulin G Treatment Outcome Natural Killer Cells pathology drug effects Mononuclear Leukocytes virology therapeutic use Aged Amino Acid Sequence Immunologic Cytotoxicity Membrane Glycoproteins Enzyme-Linked Immunosorbent Assay Adult Ovarian Neoplasms T-Lymphocytes Middle Age Cancer Vaccines blood Animal Viral DNA Th1 Cells Regression Analysis methods Colonic Neoplasms CD40 Ligand Neoplasms Adenocarcinoma Cell Division Cell Death adverse effects 1-Phosphatidylinositol 3-Kinase Lymph Nodes In Situ Nick-End Labeling CD80 Antigens Ligands Colorectal Neoplasms MHC Class I Genes Proto-Oncogene Proteins c-akt Phenotype Chronic Hepatitis B Phagocytosis Measles virus Ultraviolet Rays Amino Acid Sequence Homology Skin Tests Knockout Mice Phospholipase C Skin Diseases Carcinoembryonic Antigen Delayed Hypersensitivity Measles HLA-A2 Antigen Immunological Models Flow Cytometry Dendritic Cells Hepatitis B Immunologic Adjuvants Cytokines Signal Transducing Adaptor Proteins chemically induced Melanoma T-Lymphocyte Epitopes Drug Dose-Response Relationship Synthetic Vaccines Headache Neoplasm Proteins Marmota pathogenicity Biopsy Immunotherapy Survival Analysis K562 Cells pharmacology Antigen Receptors-T-Cell Middle Aged Tretinoin Cytotoxic T-Lymphocytes Congenic Mice toxicity Self Tolerance Brain Avipoxvirus Immunologic Receptors Liver Regeneration Viremia Tetanus Toxoid Signal Transduction Peptide Fragments Neurons secretion drug therapy Cell Line Neoplasm Staging Woodchuck Hepatitis B Virus administration & dosage Cell Aging Saponins Interleukin-2 isolation & purification prevention & control Pain deficiency Tumor Cell Line Pilot Projects Carrier Proteins Messenger RNA Follow-Up Studies Time Factors Transgenic Mice therapy Liver Reverse Transcriptase Polymerase Chain Reaction Skin Tumor Necrosis Factor Central Nervous System Infections Cell Differentiation Lymphocyte Activation
Last updated on Thursday, April 02, 2020